产品: | CPSF6 抗体 |
货号: | DF9397 |
描述: | Rabbit polyclonal antibody to CPSF6 |
应用: | WB |
反应: | Human, Mouse |
预测: | Bovine, Horse, Dog |
分子量: | 59 kDa; 59kD(Calculated). |
蛋白号: | Q16630 |
RRID: | AB_2842593 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF9397, RRID:AB_2842593.
展开/折叠
CFIM; CFIm68; cleavage and polyadenylation specific factor 6, 68kDa; Cleavage and polyadenylation specificity factor 68 kDa subunit; Cleavage and polyadenylation specificity factor subunit 6; cleavage factor Im complex 68 kDa subunit; CPSF 68 kDa subunit; Cpsf6; CPSF6_HUMAN; HPBRII 4; HPBRII 7; Pre mRNA cleavage factor Im 68 kDa subunit; pre-mRNA cleavage factor I, 68kD subunit; pre-mRNA cleavage factor Im (68kD); Pre-mRNA cleavage factor Im 68 kDa subunit; Protein HPBRII 4/7; Protein HPBRII-4/7;
抗原和靶标
- Q16630 CPSF6_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MADGVDHIDIYADVGEEFNQEAEYGGHDQIDLYDDVISPSANNGDAPEDRDYMDTLPPTVGDDVGKGAAPNVVYTYTGKRIALYIGNLTWWTTDEDLTEAVHSLGVNDILEIKFFENRANGQSKGFALVGVGSEASSKKLMDLLPKRELHGQNPVVTPCNKQFLSQFEMQSRKTTQSGQMSGEGKAGPPGGSSRAAFPQGGRGRGRFPGAVPGGDRFPGPAGPGGPPPPFPAGQTPPRPPLGPPGPPGPPGPPPPGQVLPPPLAGPPNRGDRPPPPVLFPGQPFGQPPLGPLPPGPPPPVPGYGPPPGPPPPQQGPPPPPGPFPPRPPGPLGPPLTLAPPPHLPGPPPGAPPPAPHVNPAFFPPPTNSGMPTSDSRGPPPTDPYGRPPPYDRGDYGPPGREMDTARTPLSEAEFEEIMNRNRAISSSAISRAVSDASAGDYGSAIETLVTAISLIKQSKVSADDRCKVLISSLQDCLHGIESKSYGSGSRRERSRERDHSRSREKSRRHKSRSRDRHDDYYRERSRERERHRDRDRDRDRERDREREYRHR
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - Q16630 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S38 | Phosphorylation | Uniprot | |
T55 | Phosphorylation | Uniprot | |
Y74 | Phosphorylation | Uniprot | |
T75 | Phosphorylation | Uniprot | |
Y76 | Phosphorylation | Uniprot | |
T77 | Phosphorylation | Uniprot | |
K79 | Acetylation | Uniprot | |
K79 | Ubiquitination | Uniprot | |
S137 | Phosphorylation | Uniprot | |
K146 | Ubiquitination | Uniprot | |
T157 | Phosphorylation | Uniprot | |
C159 | S-Nitrosylation | Uniprot | |
K161 | Acetylation | Uniprot | |
K161 | Ubiquitination | Uniprot | |
S165 | Phosphorylation | Uniprot | |
K185 | Acetylation | Uniprot | |
K185 | Ubiquitination | Uniprot | |
R194 | Methylation | Uniprot | |
R202 | Methylation | Uniprot | |
R204 | Methylation | Uniprot | |
R206 | Methylation | Uniprot | |
Y384 | Phosphorylation | Uniprot | |
Y390 | Phosphorylation | Uniprot | |
R392 | Methylation | Uniprot | |
Y395 | Phosphorylation | Uniprot | |
T404 | Phosphorylation | Uniprot | |
T407 | Phosphorylation | Uniprot | |
S410 | Phosphorylation | Uniprot | |
S425 | Phosphorylation | Uniprot | |
S426 | Phosphorylation | Uniprot | |
S427 | Phosphorylation | Uniprot | |
S434 | Phosphorylation | Uniprot | |
S437 | Phosphorylation | Uniprot | |
S443 | Phosphorylation | Uniprot | |
K459 | Ubiquitination | Uniprot | |
K483 | Ubiquitination | Uniprot | |
S487 | Phosphorylation | Uniprot | |
S489 | Phosphorylation | Uniprot | |
S494 | Phosphorylation | Uniprot | |
S500 | Phosphorylation | Uniprot | |
S502 | Phosphorylation | Uniprot | |
S511 | Phosphorylation | Uniprot | |
S513 | Phosphorylation | Uniprot | |
Y520 | Phosphorylation | Uniprot | |
Y521 | Phosphorylation | Uniprot | |
S525 | Phosphorylation | Uniprot |
研究背景
Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation. The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs. CPSF6 enhances NUDT21/CPSF5 binding to 5'-UGUA-3' elements localized upstream of pA signals and promotes RNA looping, and hence activates directly the mRNA 3'-processing machinery. Plays a role in mRNA export.
Phosphorylated. Phosphorylated in the Arg/Ser-rich domain by SRPK1, in vitro.
Symmetrically dimethylated on arginine residues in the GAR motif by PRMT5 in a WDR77- and CLNS1A-dependent manner. Asymmetrically dimethylated on arginine residues in the GAR motif by PRMT1.
Nucleus. Nucleus>Nucleoplasm. Nucleus speckle. Cytoplasm.
Note: Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm) (PubMed:19864460). Colocalizes with PSPC1 in punctate subnuclear structures often located adjacent to nuclear speckles, called paraspeckles, and corresponding to interchromatin granules-associated zones (IGAZs) (PubMed:17267687). Distribution in speckles and paraspeckles varies during the cell cycle (PubMed:17267687). Associates at sites of active transcription on nascent perichromatin fibrils (PFs) and perichromatin granules (PubMed:17267687). Nuclear import is mediated via interaction with TNPO3 independently of CPSF6 phosphorylation status (PubMed:30916345).
Component of the cleavage factor Im (CFIm) complex which is a heterotetramer composed of two subunits of NUDT21/CPSF5 and two subunits of CPSF6 or CPSF7 or a heterodimer of CPSF6 and CPSF7. The cleavage factor Im (CFIm) complex associates with the CPSF and CSTF complexes to promote the assembly of the core mRNA 3'-processing machinery. Associates with the exon junction complex (EJC). Associates with the 80S ribosome particle. Interacts (via the RRM domain) with NUDT21/CPSF5; this interaction is direct and enhances binding to RNA. Interacts (via Arg/Ser-rich domain) with FIP1L1 (preferentially via unphosphorylated form and Arg/Glu/Asp-rich domain); this interaction mediates, at least in part, the interaction between the CFIm and CPSF complexes and may be inhibited by CPSF6 hyper-phosphorylation. Interacts (via N-terminus) with NXF1; this interaction is direct. Interacts with SRSF3. Interacts with SRSF7. Interacts with SNRNP70. Interacts with TRA2B/SFRS10. Interacts with UPF1. Interacts with UPF3B. Interacts with VIRMA. Interacts (via Arg/Ser-rich domain) with TNPO3; promoting nuclear import of CPSF6 independently of its phosphorylation status.
Contains an Arg/Ser-rich domain composed of arginine-serine dipeptide repeats within the C-terminal region that is necessary and sufficient for activating mRNA 3'-processing and alternative polyadenylation (APA).
Belongs to the RRM CPSF6/7 family.
研究领域
· Genetic Information Processing > Translation > mRNA surveillance pathway.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.